Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Mirati Therapeutics Inc. buy B. Riley

Start price
€33.71
09.08.23 / 50%
Target price
-
09.08.24
Performance (%)
60.19%
Price
€53.84
23.01.24
Summary
This prediction is currently active. With a performance of 60.19% the BUY prediction by B__Riley is a big success. This prediction currently runs until 09.08.24. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Mirati Therapeutics Inc. - -
iShares Core DAX® -0.205% 2.949%
iShares Nasdaq 100 1.613% 5.877%
iShares Nikkei 225® -0.740% -1.256%
iShares S&P 500 0.267% 3.240%

Comments by B__Riley for this prediction

In the thread Mirati Therapeutics Inc. diskutieren

Mirati Therapeutics, Inc. (NASDAQ: MRTX) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating.
Ratings data for MRTX provided by MarketBeat